From: Determination of the increased risk of developing atrial fibrillation in fibromyalgia syndrome
FMS group n:70 | Control group n:70 | p | |
---|---|---|---|
Heart rate (beat/min) | 82.6 ± 9.0 | 81.8 ± 9.9 | 0.513 |
LVEF (%) | 64.4 ± 4.8 | 66.9 ± 4.4 | 0.724 |
LVEDD (cm) | 4.4 ± 3.0 | 4.4 ± 2.7 | 0.874 |
LVESD (cm) | 2.9 ± 0.7 | 2.8 ± 0.8 | 0.816 |
IVSD (cm) | 0.9 ± 0.2 | 0.9 ± 0.1 | 0.523 |
PWD (cm) | 0.9 ± 0.2 | 0.9 ± 0.3 | 0.687 |
E (m/s) | 0.71 ± 0.09 | 0.76 ± 0.05 | 0.035 |
A (m/s) | 0.63 ± 0.08 | 0.61 ± 0.05 | 0.366 |
E/A (Ratio) | 1.15 ± 0.16 | 1.26 ± 0.06 | 0.001 |
DT (ms) | 186 ± 23 | 179 ± 21 | 0.254 |
IVRT (ms) | 99 ± 9.4 | 92 ± 6.7 | < 0.001 |
E/E’ lateral | 6.1 ± 2.7 | 6.0 ± 2.2 | 0.494 |
E/E’ septal | 7.4 ± 2.6 | 7.1 ± 2.1 | 0.608 |
E/E’ m | 6.7 ± 2.3 | 6.5 ± 1.8 | 0.726 |
LA dimension (cm) | 3.3 ± 0.4 | 3.1 ± 0.3 | 0.009 |